Phase 2 CagriSema in T2D (Frias et al., 2023): CagriSema produced superior weight loss and glycemic improvement vs either monotherapy over 32 weeks
Vitamin D3: The Skin-Barrier Vitamin So Many People Are Missing Vitamin D3 adds another layer of support, particularly in reinforcing the skin barrier and calming inflammation
On the basis of the dosing conditions trial, which was completed at the time of planning the food-effect trial, it was assumed that the standard deviation for the log-transformed AUC 024h,semaglutide,day10 was 0.60
The same group of patients exhibited elevated ALT but reduced APAP glucuronide levels, suggesting that UGT1A6*2 polymorphism is a modifier of acetaminophen glucuronidation in patients with abnormal liver function
Dungan KM, Povedano ST, Forst T, et al